Chord Energy Valuation
Is CHRD * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CHRD * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CHRD * (MX$3000) is trading below our estimate of fair value (MX$6321.04)
Significantly Below Fair Value: CHRD * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CHRD *?
Other financial metrics that can be useful for relative valuation.
What is CHRD *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$7.60b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2x |
Enterprise Value/EBITDA | 4.2x |
PEG Ratio | 0.7x |
Price to Earnings Ratio vs Peers
How does CHRD *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 11.8x | ||
VISTA A Vista Energy. de | 13.5x | 28.5% | Mex$78.0b |
PRIO3 Prio | 7.8x | 22.9% | R$39.4b |
CIVI Civitas Resources | 9.7x | 21.7% | US$7.6b |
VNOM Viper Energy | 16.3x | 0.1% | US$6.6b |
CHRD * Chord Energy | 8.1x | 12.2% | Mex$7.6b |
Price-To-Earnings vs Peers: CHRD * is good value based on its Price-To-Earnings Ratio (8.1x) compared to the peer average (10.6x).
Price to Earnings Ratio vs Industry
How does CHRD *'s PE Ratio compare vs other companies in the Global Oil and Gas Industry?
Price-To-Earnings vs Industry: CHRD * is good value based on its Price-To-Earnings Ratio (8.1x) compared to the Global Oil and Gas industry average (10.2x).
Price to Earnings Ratio vs Fair Ratio
What is CHRD *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 8.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CHRD *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$3,000.00 | Mex$3,556.16 +18.5% | 10.5% | Mex$4,371.97 | Mex$3,103.76 | n/a | 9 |
May ’25 | n/a | Mex$3,604.67 0% | 10.1% | Mex$4,459.24 | Mex$3,114.66 | n/a | 10 |
Apr ’25 | n/a | Mex$3,288.00 0% | 11.0% | Mex$3,851.41 | Mex$2,808.67 | n/a | 8 |
Mar ’25 | n/a | Mex$3,276.08 0% | 12.3% | Mex$3,897.26 | Mex$2,722.98 | n/a | 8 |
Feb ’25 | n/a | Mex$3,175.75 0% | 9.5% | Mex$3,860.89 | Mex$2,757.78 | n/a | 12 |
Jan ’25 | n/a | Mex$3,281.18 0% | 8.2% | Mex$3,894.14 | Mex$2,890.32 | n/a | 12 |
Dec ’24 | n/a | Mex$3,314.11 0% | 8.0% | Mex$3,895.56 | Mex$2,891.37 | n/a | 12 |
Nov ’24 | n/a | Mex$3,360.05 0% | 8.0% | Mex$4,007.77 | Mex$2,974.65 | n/a | 11 |
Oct ’24 | n/a | Mex$3,281.09 0% | 9.2% | Mex$3,908.05 | Mex$2,652.53 | n/a | 11 |
Sep ’24 | Mex$2,750.00 | Mex$3,101.79 +12.8% | 10.0% | Mex$3,768.34 | Mex$2,557.70 | n/a | 11 |
Aug ’24 | n/a | Mex$3,005.61 0% | 10.9% | Mex$3,719.14 | Mex$2,524.31 | n/a | 10 |
Jul ’24 | n/a | Mex$3,076.74 0% | 14.5% | Mex$4,226.66 | Mex$2,566.80 | n/a | 10 |
Jun ’24 | n/a | Mex$3,156.88 0% | 14.7% | Mex$4,344.01 | Mex$2,638.07 | n/a | 10 |
May ’24 | n/a | Mex$3,290.32 0% | 15.6% | Mex$4,530.93 | Mex$2,696.99 | n/a | 10 |
Apr ’24 | n/a | Mex$3,232.54 0% | 9.2% | Mex$3,799.45 | Mex$2,713.89 | n/a | 9 |
Mar ’24 | n/a | Mex$3,407.75 0% | 9.8% | Mex$4,024.37 | Mex$2,756.42 | n/a | 9 |
Feb ’24 | n/a | Mex$3,466.72 0% | 9.9% | Mex$4,123.66 | Mex$2,824.43 | n/a | 9 |
Jan ’24 | Mex$2,594.47 | Mex$3,653.84 +40.8% | 10.6% | Mex$4,329.00 | Mex$2,978.67 | n/a | 7 |
Dec ’23 | Mex$2,851.00 | Mex$3,660.56 +28.4% | 11.5% | Mex$4,219.04 | Mex$2,903.01 | n/a | 7 |
Nov ’23 | Mex$3,056.60 | Mex$3,549.61 +16.1% | 15.0% | Mex$4,359.17 | Mex$2,972.16 | n/a | 7 |
Oct ’23 | Mex$2,685.39 | Mex$3,760.35 +40.0% | 14.4% | Mex$4,359.73 | Mex$3,013.64 | n/a | 6 |
Sep ’23 | n/a | Mex$3,634.68 0% | 13.9% | Mex$4,265.50 | Mex$3,003.87 | Mex$2,750.00 | 6 |
Aug ’23 | Mex$2,434.00 | Mex$3,852.59 +58.3% | 12.2% | Mex$4,382.58 | Mex$3,057.62 | n/a | 6 |
Jul ’23 | n/a | Mex$4,004.06 0% | 14.7% | Mex$4,613.30 | Mex$3,069.02 | n/a | 6 |
Jun ’23 | n/a | Mex$4,132.67 0% | 15.1% | Mex$4,730.69 | Mex$3,147.11 | n/a | 6 |
May ’23 | n/a | Mex$4,053.22 0% | 14.3% | Mex$4,722.59 | Mex$3,168.57 | n/a | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.